Differentially expressed genes in postperfusion biopsies predict early graft dysfunction after liver transplantation

Transplantation

Volumn 82, Issue 5, 2006, Pages 699-704

  Berberat, Pascal O ^a   Friess, Helmut ^a   Schmied, Bruno ^a   Kremer, Michael ^a   Gragert, Stefanie ^a   Flechtenmacher, Christa ^a   Schemmer, Peter ^a   Schmidt, Jan ^a   Kraus, Thomas ^a   Uhl, Waldemar ^a   Meuer, Stefan ^a   Büchler, Markus W ^a   Giese, Thomas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Gene expression; I R injury; Liver transplantation; Risk score

Indexed keywords

ANTIGEN; C REACTIVE PROTEIN; CD 274 ANTIGEN; CONNECTIVE TISSUE GROWTH FACTOR; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ACCURACY; ADULT; ARTICLE; CD274 GENE; CELL FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GENE EXPRESSION; GRAFT DYSFUNCTION; HUMAN; HUMAN TISSUE; HYPOTHESIS; INFLAMMATION; INTERVENTION STUDY; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NUCLEOTIDE SEQUENCE; POSTOPERATIVE COMPLICATION; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REPERFUSION INJURY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TWO TAILED TEST; UNINDEXED SEQUENCE; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; BIOPSY; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; REOPERATION; REPERFUSION INJURY; ROC CURVE; SURVIVAL ANALYSIS;

EID: 33748708826     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000233377.14174.93     Document Type: Article

References (19)

1. Keeffe EB. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 2001; 120(3): 749.
2. Loinaz C, Gonzalez EM. Marginal donors in liver transplantation. Hepatogastroenterology 2000; 47(31): 256.
3. Plevak DJ, Findlay JY. Critical care issues in liver transplantation. Liver Transpl 2000; 6(4 Suppl 1): S2.
4. Markmann JF, Markmann JW, Desai NM, et al. Operative parameters that predict the outcomes of hepatic transplantation. J Am Coll Surg 2003; 196(4): 566.
5. Markmann JF, Markmann JW, Markmann DA, et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants. Transplantation 2001; 72(6): 1113.
6. Adam R, Bismuth H, Diamond T, et al. Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet 1992; 340(8832): 1373.
7. Abraham S, Furth EE. Quantitative evaluation of histological features in "time-zero" liver allograft biopsies as predictors of rejection or graft failure: receiver-operating characteristic analysis application. Hum Pathol 1996; 27(10): 1077.
8. Busquets J, Figueras J, Serrano T, et al. Postreperfusion biopsies are useful in predicting complications after liver transplantation. Liver Transpl 2001; 7(5): 432.
9. Gaffey MJ, Boyd JC, Traweek ST, et al. Predictive value of intraoperative biopsies and liver function tests for preservation injury in orthotopic liver transplantation. Hepatology 1997; 25(1): 184.
10. Howard TK, Klintmalm GB, Cofer JB, et al. The influence of preservation injury on rejection in the hepatic transplant recipient. Transplantation 1990; 49(1): 103.
11. Kakizoe S, Yanaga K, Starzl TE, Demetris AJ. Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: considerations of preservation and early immunological injury. Hepatology 1990; 11(6): 932.
12. Lemasters JJ, Thurman RG. Reperfusion injury after liver preservation for transplantation. Annu Rev Pharmacol Toxicol 1997; 37: 327.
13. Their M, Ronnholm K, Sairanen H, et al. Serum C-reactive protein in pediatric kidney and liver transplant patients. Pediatr Transplant 2002; 6(2): 153.
14. Yamane A, Seetharam L, Yamaguchi S, et al. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 1994; 9(9): 2683.
15. Moriga T, Arii S, Takeda Y, et al. Protection by vascular endothelial growth factor against sinusoidal endothelial damage and apoptosis induced by cold preservation. Transplantation 2000; 69(1): 141.
16. Boros P, Tarcsafalvi A, Wang L, et al. Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation 2001; 72(5): 805.
17. Mazanet MM, Hughes CC. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol 2002; 169(7): 3581.
18. Mueller DL. E3 ubiquitin ligases as T cell anergy factors. Nat Immunol 2004; 5(9): 883.
19. Avihingsanon Y, Ma N, Pavlakis M, et al. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol 2005; 16(6): 1542.